NL8105791A - Nieuwe heterocyclische aminoalkylverbindingen, werkwijze voor hun bereiding alsmede de therapeutische toepassing van deze verbindingen. - Google Patents

Nieuwe heterocyclische aminoalkylverbindingen, werkwijze voor hun bereiding alsmede de therapeutische toepassing van deze verbindingen. Download PDF

Info

Publication number
NL8105791A
NL8105791A NL8105791A NL8105791A NL8105791A NL 8105791 A NL8105791 A NL 8105791A NL 8105791 A NL8105791 A NL 8105791A NL 8105791 A NL8105791 A NL 8105791A NL 8105791 A NL8105791 A NL 8105791A
Authority
NL
Netherlands
Prior art keywords
compounds
preparation
therapeutic use
novel heterocyclic
heterocyclic aminoalkyl
Prior art date
Application number
NL8105791A
Other languages
English (en)
Dutch (nl)
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8027252A external-priority patent/FR2496653A1/fr
Priority claimed from FR8123304A external-priority patent/FR2518087A2/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of NL8105791A publication Critical patent/NL8105791A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8105791A 1980-12-22 1981-12-22 Nieuwe heterocyclische aminoalkylverbindingen, werkwijze voor hun bereiding alsmede de therapeutische toepassing van deze verbindingen. NL8105791A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8027252A FR2496653A1 (fr) 1980-12-22 1980-12-22 Nouveaux derives aminoalcoyl heterocycliques, leurs procedes de preparation et leur application en therapeutique
FR8123304A FR2518087A2 (en) 1981-12-14 1981-12-14 Aminoalkyl di:hydro-naphthalene, isoquinoline and benzoxazepine cpds. - useful as analgesics and antidepressants

Publications (1)

Publication Number Publication Date
NL8105791A true NL8105791A (nl) 1982-07-16

Family

ID=26222136

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8105791A NL8105791A (nl) 1980-12-22 1981-12-22 Nieuwe heterocyclische aminoalkylverbindingen, werkwijze voor hun bereiding alsmede de therapeutische toepassing van deze verbindingen.

Country Status (11)

Country Link
US (3) US4386090A (en:Method)
AU (1) AU7875781A (en:Method)
CA (1) CA1181748A (en:Method)
DE (1) DE3150876A1 (en:Method)
ES (3) ES508670A0 (en:Method)
GB (2) GB2091250B (en:Method)
GR (1) GR78081B (en:Method)
IT (1) IT1168074B (en:Method)
LU (1) LU83850A1 (en:Method)
NL (1) NL8105791A (en:Method)
SE (1) SE8107537L (en:Method)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244594A1 (de) * 1982-12-02 1984-06-07 Hoechst Ag, 6230 Frankfurt 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung
FR2544718B1 (fr) * 1983-04-21 1985-12-20 Hexachimie Diniflumate d'ester morpholinoethylique d'acide niflumique, preparation, utilisation en therapeutique comme analgesique et anti-inflammatoire
US4745222A (en) * 1983-05-25 1988-05-17 Merrell Dow Pharmaceuticals Inc. Novel aryloxycycloalkanolaminoalkylene aryl ketones
DE3413897A1 (de) * 1984-04-13 1985-10-17 Bayer Ag, 5090 Leverkusen (beta)-naphthylalkylamine
DE3766335D1 (de) * 1986-09-17 1991-01-03 Zambeletti Spa L N-1-acylierte-(1-(phenyl- oder benzyl-))-1,2-aethylendiamine.
US5561152A (en) * 1987-08-14 1996-10-01 Merrell Pharmaceuticals Inc. Antidepressants
ZA885824B (en) * 1987-08-14 1989-04-26 Merrell Dow Pharma Novel antidepressants
US5149714A (en) * 1987-08-14 1992-09-22 Merrell Dow Pharmaceuticals Inc. Antidepressants
US5229414A (en) * 1988-01-21 1993-07-20 Imperial Chemical Industries Plc Diamine compounds
US5071845A (en) * 1988-12-28 1991-12-10 Suntory Limited Benzoxazepine derivative
US5948820A (en) 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
IT1303737B1 (it) * 1998-11-11 2001-02-23 Smithkline Beecham Spa Derivati fenilpiperidinici procedimento per la loro preparazione eloro uso come ligandi del recettore orl-1.
US6646012B2 (en) * 2001-01-16 2003-11-11 Theravance, Inc. Sodium channel modulators
CA2450579A1 (en) * 2001-06-20 2003-01-03 Merck & Co., Inc. Dipeptidyl peptidase inhibitors for the treatment of diabetes
DE60209348T2 (de) * 2001-06-20 2006-10-12 Merck & Co., Inc. Dipeptidylpeptidase-hemmer zur behandlung von diabetes
ATE435202T1 (de) * 2002-01-11 2009-07-15 Daiichi Sankyo Co Ltd Aminoalkoholderivat oder phosphonsäurederivat und diese enthaltende medizinische zusammensetzung
JP4530852B2 (ja) * 2002-07-15 2010-08-25 メルク・シャープ・エンド・ドーム・コーポレイション 糖尿病治療のためのピペリジノピリミジンジペプチジルペプチダーゼ阻害剤
JP4491346B2 (ja) * 2002-10-07 2010-06-30 メルク・シャープ・エンド・ドーム・コーポレイション 抗糖尿病ベータアミノ複素環ジペプチジルペプチダーゼ阻害剤
AU2003290577B2 (en) * 2002-11-07 2008-12-11 Merck Sharp & Dohme Corp. Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
AU2003297564A1 (en) * 2002-12-04 2004-06-23 Merck & Co., Inc. Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2004058266A1 (en) * 2002-12-20 2004-07-15 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
EP1589969A4 (en) * 2003-01-17 2008-08-13 Merck & Co Inc 3-AMINO-4-PHENYLBUTANEAN DERIVATEALS DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
EP1592689A4 (en) * 2003-01-31 2008-12-24 Merck & Co Inc 3-AMINO-4-PHENYLBUTANEAN DERIVATIVES AS DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
US7560455B2 (en) * 2003-05-14 2009-07-14 Merck & Co., Inc. 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
EP1635818B1 (en) * 2003-06-06 2010-04-07 Merck Sharp & Dohme Corp. Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2004112701A2 (en) * 2003-06-17 2004-12-29 Merck & Co., Inc. Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
US7259160B2 (en) * 2003-07-31 2007-08-21 Merck & Co., Inc. Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
EP1685092B1 (en) * 2003-09-18 2010-01-13 Takasago International Corporation Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives
US7238683B2 (en) * 2003-11-04 2007-07-03 Merck & Co., Inc. Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
CN1921847B (zh) 2004-02-24 2010-06-16 三共株式会社 氨基醇化合物
JP2007536234A (ja) * 2004-05-04 2007-12-13 メルク エンド カムパニー インコーポレーテッド 糖尿病の治療又は予防のためのジペプチジルペプチダーゼ−iv阻害剤としての1,2,4−オキサジアゾール誘導体
US7795448B2 (en) * 2004-05-06 2010-09-14 Cytokinetics, Incorporated Imidazoyl-benzamide anti-cancer agents
US7618981B2 (en) * 2004-05-06 2009-11-17 Cytokinetics, Inc. Imidazopyridinyl-benzamide anti-cancer agents
US7504413B2 (en) * 2004-05-06 2009-03-17 Cytokinetics, Inc. N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
EP1604662A1 (en) * 2004-06-08 2005-12-14 Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft 1-[(3R)-Amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid benzyl amine derivatives and related compounds as dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus
JP2009514865A (ja) * 2005-11-02 2009-04-09 サイトキネティクス・インコーポレーテッド 有糸分裂キネシン阻害剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2168929A (en) * 1936-12-12 1939-08-08 Winthrop Chem Co Inc Isoquinoline compounds and derivatives thereof
US3663608A (en) * 1969-12-10 1972-05-16 Bristol Myers Co 1-phenyl-3-aminoalkyl-1,2,3,4-tetrahydronaphthalenes and the salts thereof
US3704328A (en) * 1970-01-21 1972-11-28 James S Kaltenbronn 4- and 5-aryl-1-naphthaleneethanol compounds
US3663627A (en) * 1970-06-01 1972-05-16 Bristol Myers Co 1-indanmethanols
GB1400425A (en) * 1971-09-22 1975-07-16 Rolland Sa A Substituted 3-hydroxymethyl-isoquinolines and derivatives
US4022791A (en) * 1975-06-03 1977-05-10 Pfizer Inc. 2-Aminomethyl-3,4-dihydronaphthalenes

Also Published As

Publication number Publication date
CA1181748A (en) 1985-01-29
US4386090A (en) 1983-05-31
AU7875781A (en) 1982-07-01
ES518693A0 (es) 1983-11-01
IT1168074B (it) 1987-05-20
ES518692A0 (es) 1983-11-01
DE3150876A1 (de) 1982-07-29
IT8125722A0 (it) 1981-12-21
SE8107537L (sv) 1982-06-23
GB2137992B (en) 1985-05-09
GB2091250A (en) 1982-07-28
LU83850A1 (fr) 1983-09-02
ES8306093A1 (es) 1983-06-01
US4504663A (en) 1985-03-12
GB2091250B (en) 1984-11-14
ES8400093A1 (es) 1983-11-01
ES8400388A1 (es) 1983-11-01
US4431851A (en) 1984-02-14
ES508670A0 (es) 1983-06-01
GB8409163D0 (en) 1984-05-16
GB2137992A (en) 1984-10-17
GR78081B (en:Method) 1984-09-26

Similar Documents

Publication Publication Date Title
NL8105791A (nl) Nieuwe heterocyclische aminoalkylverbindingen, werkwijze voor hun bereiding alsmede de therapeutische toepassing van deze verbindingen.
NO154764C (no) Gel for behandling av underjordiske formasjoner.
NL189757C (nl) Werkwijze voor het continu bereiden van nitrobenzeen.
NL930056I2 (nl) Imidazodiazepine-derivaten, werkwijze en tussenpr odukten voor de bereiding ervan, deze bevattende geneesmiddelen en de therapeutische toepassing ervan.
NL7900871A (nl) Werkwijze voor de therapeutische behandeling van hyperlipidemie en hyperlipiproteinemie.
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
JPS56103113A (en) Drug for shock treatment
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NL191149C (nl) Werkwijze voor de bereiding van 3-trifluormethylpyridinederivaten.
TR20880A (tr) Akrilonitrilin aritilmasi
NL7811823A (nl) Nieuwe oximen werkwijze voor de bereiding van oxyderen en oximen bevattend therapeutisch preparaat.
NL7903853A (nl) Nieuwe derivaten van 4-amino-2-piperidinochinazoline en werkwijzen voor hun bereiding en toepassing.
NL7805849A (nl) Nieuwe benzodiazepin-6-on derivaten en werkwijzen voor hun bereiding en toepassing.
NL7803896A (nl) Nieuwe pyrrolochinoxalineverbindingen, werkwijze voor hun bereiding en geneesmiddelen.
NL7801887A (nl) Nieuwe 20,21-dinoreburnamenine-verbindingen, werkwijze voor hun bereiding en farmaceutische preparaten.
NL7808276A (nl) Nieuwe 1,3-difenoxypropaan-2-on derivaten, werkwijze voor het bereiden daarvan alsmede voornoemde derivaten bevattende geneesmiddelen.
NO803403L (no) Anordning for behandling av virke.
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.
NL7800001A (nl) Werkwijze voor de bereiding van nieuwe chromoon- derivaten en de toepassing hiervan als genees- middel tegen hartziekten.
NL7808944A (nl) Werkwijze voor de bereiding van heterocyclische zuur- stofverbindingen.
NL7606238A (nl) Werkwijze voor de bereiding van nieuwe cyclo- propanolderivaten, alsmede de toepassing ervan.
NL7607073A (nl) Werkwijze voor het bereiden van nieuwe verbin- dingen, alsmede deze verbindingen bevattende preparaten en de toepassing daarvan voor de bestrijding van schadelijk ongedierte.
BE846473A (nl) Werkwijze voor de bereiding van nieuwe n-aryl-n-(1-l-4-piperidinyl)-aryl-aceetamiden
GB2011910B (en) Process for the treatment of proteinaceous materials of animal origin
NO811134L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-derivater.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed